Target intelligence / Profile preview

Lipid peroxyl radical (LOO•) (LOO•)

Target
LOO•
Molecular classification
Other, Free radical, Reactive oxygen species
01

Overview

Lipid peroxyl radicals (LOO•) are highly reactive chemical species formed during the propagation phase of lipid peroxidation, a chain reaction that causes oxidative damage to polyunsaturated fatty acids (PUFAs) in cellular membranes (Ayala et al., 2014). These radicals are generated when a carbon-centered lipid radical reacts rapidly with molecular oxygen; the resulting peroxyl radical then abstracts a hydrogen atom from a neighboring lipid molecule, creating a lipid hydroperoxide and a new lipid radical to continue the cycle (Niki, 2014). This process leads to the loss of membrane integrity, altered fluidity, and the formation of toxic secondary products like malondialdehyde and 4-hydroxynonenal, which can damage proteins and DNA (Gaschler & Stockwell, 2017). Lipid peroxyl radicals are key drivers of ferroptosis, a form of regulated cell death characterized by iron-dependent lipid peroxidation (Stockwell et al., 2017). Pharmacological intervention typically involves chain-breaking antioxidants, such as Vitamin E or specialized small molecules like Ferrostatin-1, which donate a hydrogen atom to the peroxyl radical to terminate the chain reaction (Zelkas et al., 2020). These radicals are implicated in the progression of atherosclerosis, neurodegenerative diseases like Alzheimer's, and various inflammatory disorders (Milne et al., 2005).

Other names
Peroxyl radicalLipid peroxylLOO.ROO.Lipid hydroperoxyl radical
02

Mechanism of action

Chain-breaking antioxidant activity via hydrogen atom transfer (HAT) to neutralize the radical and terminate the lipid peroxidation chain reaction.

03

Biological functions

Cell deathOther
04

Disease associations

CancerInflammationNeurodegenerative diseaseCardiovascular diseaseOther
05

Safety considerations

Interference with physiological redox signalingPotential pro-oxidant effects at high dosesLow bioavailability of certain scavengersLack of specificity for pathological vs. physiological ROS
06

Interacting drugs

Alpha-tocopherol (Vitamin E)

7 more in the full profile.

07

Biomarkers

Malondialdehyde (MDA)4-Hydroxynonenal (4-HNE)8-iso-Prostaglandin F2alpha (8-iso-PGF2α)Thiobarbituric acid reactive substances (TBARS)

Beyond the preview

Go deeper on Lipid peroxyl radical (LOO•) (LOO•).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Lipid peroxyl radical (LOO•) (LOO•).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call